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Abstract
We report on a pair of male monozygotic twins with 22q11.2 microdeletion, discordant phenotype and discordant
deletion size. The second twin had findings suggestive of DiGeorge syndrome, while the first twin had milder
anomalies without any cardiac malformation. The second twin had presented with intractable convulsion, cyanosis
and cardiovascular failure in the fourth week of life and expired on the sixth week of life, whereas the first twin
had some characteristic facial appearance with developmental delay but no other signs of the 22q11.2
microdeletion syndrome including cardiovascular malformation. The fluorescence in situ hybridization (FISH)
analysis had shown a microdeletion on the chromosome 22q11.2 in both twins. The interphase FISH did not find
any evidence for the mosaicism. The genomic DNA microarray analysis, using HumanCytoSNP-12 BeadChip
(Illumina), was identical between the twins except different size of deletion of 22q11.2. The zygosity using
HumanCytoSNP-12 BeadChip (Illumina) microarray analysis suggested monozygosity. This observation indicates that
altered size of the deletion may be the underlying etiology for the discordance in phenotype in monozygotic
twins. We think early post zygotic events (mitotic non-allelic homologous recombination) could have been played
a role in the alteration of 22q11.2 deletion size and, thus phenotypic variability in the monozygotic twins.
Introduction
The 22q11.2 microdeletion syndrome is the most com-
mon microdeletion syndrome with an estimated inci-
dence of one in 4000 to 6,000 live births and mostly
spontaneous [1-3]. The 22q11.2 microdeletion is found
in patients with DiGeorge syndrome, Velocardiofacial
syndrome and Conotruncal anomaly face syndrome [4].
It is characterized by wide spectrum of clinical manifes-
tations, including craniofacial (cleft palate, velopharyn-
geal insufficiency), thymic and parathyroid defects as
well as cardiovascular (outflow tract and aortic arch)
malformations [5]. Almost all the cases result from a
common deletion of the chromosome 22q11.2 locus.
The FISH is the prime method for diagnosis of this
microdeletion syndrome.
Several reports have mentioned phenotypic discor-
dance between the monozygotic twins with 22q11.2
microdeletion [6-12]. No definite mechanism has been
demonstrated until now for the discordant phenotype.
However, somatic mosaicism, post zygotic second hit or
environmental effects have been proposed. We report
on a pair of monozygotic male twins with 22q11.2
microdeletion and discordant phenotype resulting from
altered deletion size.
Case Reports
Second Twin
A four weeks old baby boy was presented in the pedia-
tric emergency with recurrent intractable seizures, cen-
tral cyanosis and unconsciousness. During evaluation in
the emergency, baby had an attack of cardiopulmonary
arrest. The baby was revived and kept on the ventilator.
On physical examination tachycardia & systolic murmur
was noted. ECG was suggestive of ventricular tachycar-
dia. X-ray examination of chest showed cardiomegaly.
Repeated blood calcium level showed hypocalcemia,
despite calcium and vitamin D. The baby was suspected
to have DiGeorge Syndrome with major cardiac malfor-
mation and cardiac failure. Blood sample was sent for
22q11.2 microdeletion study. The baby was expired on
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any medium, provided the original work is properly cited.sixth week of life despite intensive care, including artifi-
cial life support assistance. There was no history of
antenatal complications. The baby was fine for first
three weeks of life. The baby was developed abnormal
movements of all limbs (tonic-clonic type) along with
up slanting of eyes in fourth week of life. The baby had
intermittent seizures initially but became intractable in
few days before referral to our hospital.
S i n c et h eb a b yh a df i n d i n g ss t r o n g l ys u g g e s t i v eo f
DiGeorge syndrome, the FISH study to detect a possible
deletion in the critical 22q11.2 region was done using
DNA probe specific for the 22q11.2 locus. The FISH
was done using 1 ml of blood (0.5 ml heparinized for
the metaphase and 0.5 ml EDTA for the interphase
cells) obtained from the patient as described before
[13-15]. In brief, the metaphase spreads were prepared
from the phytohaemagglutinin stimulated human per-
ipheral blood lymphocytes using standard cytogenetic
technique. The interphase spreads were prepared from
the blood nucleated cells (both twins), buccal cells (first
twins only) and urinary cells (first twins only) after
washing in phosphate buffer saline solution three times
before 30 minutes of hypotonic treatment (50 mMol
KCL) and the fixation in methanol:acetic acid solution
(3:1 ratio). The cells (interphase & metaphase) were re-
suspended in 100 ul of fresh fixative. Approximately 20
ul cell suspensions were used to prepare a slide (inter-
phase or metaphase). FISH probe was made from the
PAC clone (RP5-882J5 obtained from Uniba Biologia,
Italy, by curtsy of Prof. M Rocchi). The PAC clone was
g r o w ni nL Bb r o t h ,D N Ae x t r a c t e da n da b o u to n eu g
DNA labeled with red flurochrome (Cy3) by nick trans-
lation method. About 300 ng labeled probe per slide
was used for FISH. The FISH analysis was carried out
using Olympus BX51 microscope with epifluorescence
attachment and image was captured through the
Applied Spectral Imaging system (Israel). The FISH
result showed 94% interphase nuclei and 100% meta-
phase nuclei with hemizygous 22q11.2 deletion (Table 1;
Figure 1). Normal control cases displayed two signals in
approximately 98% interphase and 100% metaphase
nuclei.
First Twin
The first twin was referred to our hospital (pediatrics
outpatient department) at 13 months of age due to dys-
morphic features & developmental delay and later to
our department for the 22q11.2 microdeletion study. He
had few episodes of upper respiratory infections, swal-
lowing difficulties and one episode of convulsion in the
first year of life. His developmental milestones were
delayed, unable to speak or walk even at 13 months of
age. The baby had broad nose, square shaped tip of
nose, thin upper lip, wide philtrum, folded pinna, low
set ears and mild hypertelorism, telecanthus & squint
(Figure 2A). His weight and length was normal however,
he had relatively small head (head circumference was 41
cm at 13 months i.e., below fifth percentile). His cry had
Table 1 is showing detailed FISH results of twins
Parameters 22q11.2 one signal 22q11.2 two signals 22q11.2 three/four signals Remarks*
Second Twin
Uncultured Blood 940 055 005 94% hemizygous deletion
Cultured Blood
Metaphase 010 000 000 100% hemizygous deletion
Interphase 120 005 001 95% hemizygous deletion
First Twin
Uncultured Blood 850 072 003 92% hemizygous deletion
Cultured Blood
Metaphase 025 000 000 100% hemizygous deletion
Interphase 110 006 001 94% hemizygous deletion
Buccal cells 051 003 000 94.4% hemizygous deletion
Urinary Cells 025 002 000 92.6% hemizygous deletion
Mother
Cultured Blood
Metaphase 000 010 000 Normal dizygous 22q11.2 locus
Interphase 007 500 002 98.2% normal dizygous
Father
Cultured Blood
Metaphase 000 010 000 Normal dizygous 22q11.2 locus
Interphase 008 500 003 97.8% normal dizygous
*In general < 10% mosaicism with 22q11.2 interphase FISH seems clinically insignificant
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palate. Ophthalmologic & auditory examination revealed
no abnormality. Extensive cardiovascular work up
including the echocardiography was normal. MRI scan
of head and brain was also normal. There was no hypo-
calcemia. Conventional cytogenetics from the lympho-
cyte culture was normal. Since the patient had co-twin
with 22q11.2 microdeletion and he has some findings
suggestive of 22q11.2 microdeletion syndrome the FISH
study to detect a possible deletion in the critical 22q11.2
region was done. The interphase FISH result showed
92% nuclei with hemizygous deletion for the 22q11.2
locus (Figure 2B) in the blood (mesodermal origin),
94.4% in the buccal cells (ectodermal origin) and 92.6%
in the urinary cells (mainly endodermal origin). FISH on
metaphase spread picked up deletion in all the 25 meta-
phases studied (Table 1; Figure 2C).
The twins were born to a 25 year-old mother (first
pregnancy) at term by cesarean section delivery in a pri-
vate nursing home. The second twin was 2400 gm at
birth whereas his brother (the first twin) was 2700 gm
at birth. Records of the length and head circumference
at birth were not available. There was no similar pro-
blem in the family in either parental side. Parents were
screened for the 22q11.2 microdeletion and were found
negative for the deletion.
Genomic DNA Microarray Analysis
DNA microarray study was carried out to find out rea-
son for discordance using HumanCytoSNP-12 BeadChip
(Illumina). The DNA was extracted from 250 uL of
stored EDTA blood sample using Qiagen micro kit. The
DNA quality and quantity was checked using agarose
gel & Nanodrop. The concentration of DNA was nor-
malized to 50 ng/ul. About 200 ng of DNA was used for
the microarray study. The DNA sample denatured and
isothermally amplified in an overnight step (whole-gen-
ome amplification uniformly increases the amount of
the DNA sample by several thousand-fold without intro-
ducing large amounts of amplification bias). The ampli-
fied product was then fragmented using controlled
enzymatic process using end-point fragmentation. After
an isopropanol precipitation, the fragmented DNA was
collected by centrifugation at 4°C and resuspended in
hybridization buffer. The BeadChip was prepared for
hybridization in a capillary flow-through chamber. Sam-
ples were applied to a BeadChip and divided by an
IntelliHyb
® seal. The loaded BeadChip was incubated
overnight in the Illumina Hybridization Oven. The
amplified and fragmented DNA samples anneal to
locus-specific 50-mers (covalently linked to one of up to
300,000 bead types) during hybridization. Unhybridized
and non-specifically hybridized DNA was washed away,
and the BeadChip was prepared for staining and exten-
sion. BeadChip single-base extension of the oligo on the
BeadChip, using the captured DNA as template, incor-
porates detectable labels on the BeadChip and deter-
mines the genotype call for the sample. Image captured
and analysed on iScan System. The iScan Reader uses a
laser to excite the fluor of the single-base extension pro-
duct on the beads of the BeadChip. Light emissions
from these fluors are then recorded in high-resolution
images of the BeadChip. The data from these images
were analyzed using Illumina’s KaryoStudio Module.
The microarray analysis showed deletion in the
22q11.21 and gains in 8p23.2-23.3 & 14q11.2 in both
the twins. The twins were perfect match, excepting big-
ger size (~0.14 MB) of deletion in the second twin at
22q11.21 locus (Table 2).
Discussion
We report a pair of monozygotic twins with 22q11.2
microdeletion and the discordant phenotype. The sec-
ond twin presented with the classical DiGeorge Syn-
drome whereas the first twin presented with
developmental delay and mild dysmorphic features. We
have tried to find out zygosity of the twins however as
one of the twin was very sick and did not provide time
to investigate, we were unable to provide absolute proof
for the zygosity. However, genomic DNA analysis on
Illumina Beadchip 300K mic r o a r r a ys h o w e dt h a tt w i n s
Figure 1 is showing 22q11.2 FISH with deletion on interphase
and metaphase cells obtained from peripheral blood
lymphocyte culture.
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The microarray analysis and identical sex of the twins
s u g g e s tt h a tt h et w i n sw e r elikely to be monozygotic.
The twin research, in particular monozygotic, is a
powerful tool for the study of discordances and testing
hypotheses, particularly gene-environment interactions.
It is generally presumed that the monozygotic twins are
genetically identical and that the phenotypic differences
between twins are mainly due to environmental factors.
However, the genetic and the epigenetic differences
between the monozygotic twins have been described
[16,17]. The phenotypic variability is well known with
A B
C
Figure 2 A is showing broad nose, square shaped tip of nose, thin upper lip, wide philtrum, low set ears and mild hypertelorism and
telecanthus. B is showing 22q11.2 FISH with deletion on interphase and metaphase cells obtained from peripheral blood lymphocyte culture. C
is showing 22q11.2 FISH on uncultured peripheral blood nucleated cells (interphase cells) with and without deletions (arrow).
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related or twins [7,18-21]. The phenotypic variability is
also reported in the monozygotic twins repeatedly
[6-12]. The frequent observation of variability of clinical
symptoms with the 22q11.2 microdeletion in the mono-
zygotic twins suggests underlying scientific reasons. The
reasons for the phenotypic variability in the monozygo-
tic twins could be due to various mechanisms such as
the differences in size of deletion, somatic mosaicism,
differences in copy number variations (CNV), differences
in epigenetic changes, differences in modifying genetic
factors, differences in intrauterine environment or twin-
ning process itself.
Our likely explanation for the discordant phenotype is
t h ed i f f e r e n c e si nt h es i z eo ft h ed e l e t i o nb e t w e e nt h e
twins. We have found a difference of 0.14 MB size
between the twins. Although the differences in size of
the deletion between monozygotic twins is unlikely
however this may be possible with this syndrome as
22q11.2 locus contains several (at least eight) low copy
repeat (LCR) DNA segments of more than 95%
sequence homology [22]. The LCR (long stretches of
repeated DNA sequence) makes the DNA unstable
through non-allelic homologous recombination during
cell division. The LCR take part in a homologous
recombination involving unequal inter and intrachromo-
somal crossover, either in the meiosis or in the mitosis.
This recombination leads to DNA loss or gains, thus the
size of the deletion. The literatures on the differences in
the size of 22q11.2 microdeletion with the phenotypic
difference are contradictory, some agree [23] whereas
others disagree [18,20,24-26]. Our DNA microarray ana-
lysis data showed altered size of the deletion between
the twins, about 0.14 MB bigger deletion in the second
Table 2 is showing microarray results of twins
Positive Findings First Twin (Milder) Second Twin (Severe) Remarks
Chromosome 8 Gain Gain 8p subtelomeric region
Locus p23.3-p23.2 p23.3-p23.2 First twin had larger size of gain (4880 bp)
Start 2190549 2190549 No differences in numbers of genes
End 2480256 2475376
Size (~0.3 MB) 0289707 0284827
Value 3 3
CNV Index 0 0
Number of Markers 33 32
Genes 0 0
Chromosome 14 Gain Gain 14q pericentromeric region
Locus q11.2 q11.2 Identical gain size
Start 19283777 19283777 No differences in numbers of genes
End 19494891 19494891
Size ((~0.2 MB) 00211114 00211114
Value 3 3
CNV Index 1 1
Number of Markers 14 14
Genes 6 6
Chromosome 22 Loss Loss DiGeorge syndrome 1 or Velocardiofacial
Locus q11.21 q11.21 syndrome
Start 17257787 17118296 Second twin had large deletion
End 19792353 19792353 (139491 bp; proximal deletion)
Size (> 2.5 MB) 2534566 2674057 One gene more lost in second twin
Value 1 1 (GGT3P)
CNV Index 2 2
Number of Markers 447 452
Genes 65* 66#
* DGCR6; PRODH; KIAA1647; DGCR9; DGCR10; DGCR2; DGCR11; DGCR14; TSSK2; GSC2; SLC25A1; CLTCL1; HIRA; MRPL40; C22orf39; C22orf39; UFD1L; CDC45L;
CLDN5; LOC150185; SEPT5; GP1BB; TBX1; GNB1L; C22orf29; TXNRD2; COMT; COMT; COMT; COMT; ARVCF; C22orf25; MIR185; DGCR8; MIR1306; TRMT2A; RANBP1;
ZDHHC8; LOC150197; RTN4R; MIR1286; DGCR6L; LOC375133; RIMBP3; ZNF74; SCARF2; KLHL22; MED15; POM121L4P; TMEM191A; PI4KA; SERPIND1; SNAP29; CRKL;
AIFM3; AIFM3; LZTR1; THAP7; FLJ39582; MGC16703; P2RX6; P2RX6; SLC7A4; P2RX6P; LOC400891 (First Twin)
# GGT3P; DGCR6; PRODH; KIAA1647; DGCR9; DGCR10; DGCR2; DGCR11; DGCR14; TSSK2; GSC2; SLC25A1; CLTCL1; HIRA; MRPL40; C22orf39; C22orf39; UFD1L;
CDC45L; CLDN5; LOC150185; SEPT5; GP1BB; TBX1; GNB1L; C22orf29; TXNRD2; COMT; COMT; COMT; COMT; ARVCF; C22orf25; MIR185; DGCR8; MIR1306; TRMT2A;
RANBP1; ZDHHC8; LOC150197; RTN4R; MIR1286; DGCR6L; LOC375133; RIMBP3; ZNF74; SCARF2; KLHL22; MED15; POM121L4P; TMEM191A; PI4KA; SERPIND1;
SNAP29; CRKL; AIFM3; AIFM3; LZTR1; THAP7; FLJ39582; MGC16703; P2RX6; P2RX6; SLC7A4; P2RX6P; LOC400891 (Second Twin)
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ence in size of the deletion was not expected to be
detectable by the FISH. Hence, we may conclude that
most of the negative studies on size using FISH
[18,20,24-26] may not be correct. The difference in the
size with the phenotypic discordance was observed with
other microdeletion syndromes viz., Yq microdeletion
[27], Wolf-Hirschhorn Syndrome [28], etc. Our microar-
ray analysis found deletion in 22q11.21 in both the
twins, except the bigger size (~0.14 MB) of the deletion
containing GGT3P gene (gamma-glutamyltransferase 3
pseudogene) in the second twin. The GGT3P gene initi-
ates extracellular glutathione breakdown and catalyzes
the transfer of the glutamyl moiety of glutathione to
amino acids/dipeptide acceptors. The GGT3P gene
increases ceruloplasmin and oxidase activity. Whether
this has any role with cardiac development is yet to be
linked. Thus genotypic differences i.e., the size of the
deletion may be likely explanation for the phenotypic
differences. The early post zygotic event could have
been played a role in the alteration of 22q11.2 deletion
size and, thus the phenotypic variability in the monozy-
gotic twins.
Other possible explanation for the discordant pheno-
type in the monozygotic twins is the somatic mosaicism
[29,30], particularly in the first twin with milder pheno-
type. Somatic mosaicism is usually defined by the pre-
sence of genetically distinct populations of somatic cells
in an organism. Any genetic difference between the
monozygotic twins represents an extreme example of
the somatic mosaicism. This can result in a milder dis-
ease phenotype. The somatic mosaicism for pathogen-
esis may be seen as a rule rather than exception. We
evaluated for mosaicism by interphase FISH by examin-
ing large number of cells and found no evidence of
mosaicism in all three types of tissues (blood i.e., meso-
derm, buccal i.e., ectoderm and urinary cells i.e., endo-
derm) in the first twin who had milder phenotype. The
second twin with classic 22q11.2 microdeletion syn-
drome displayed approximately 92% interphase cells
with 22q11.2 hemizygous deletion in blood cells. The
first twin with milder phenotype displayed approxi-
mately 94% interphase cells with 22q11.2 hemizygous
deletion (uncultured blood, buccal & urinary cells; Table
1). All the metaphase cells displayed 22q11.2 hemizy-
gous deletion in both the twins. Thus, the mosaicism as
underlying etiology for the twin discordance was ruled
out.
The other explanation for the discordant phenotype
could be the differences in the structural variations in
genome. An important development in human genetics
is the discovery of substantial large-scale structural var-
iation changing the chromosomal architecture (such as
deletions, duplications, insertions, inversions, and more
complex rearrangements) and occurring both in pheno-
typically normal as well as abnormal subjects. The most
explored subtype of structural variation involves changes
affecting copy number of DNA segments (denoted as
copy number variation or CNV), often involving frag-
ments of chromosomes that are considerable in size. In
recent years genomic studies using microarray platform
provides genomic explanation (CNV) for phenotypic dis-
cordance in the monozygotic twins in schizophrenia
[31,32], parkinsonism/dementia [10], etc. It is now well
known that the monozygotic twins have CNV leading to
differences in the phenotype [10,33]. The CNV have
shown to confer increased risk for the congenital cardio-
vascular disorders such as the tetralogy of Fallot [33].
Similarly, in a mice experiment with low copy transgenic
manifest ear disorders only, while the mice with high
copy transgenic presents with reduced viability and mul-
tiple anomalies that were similar to humans VCFS/DGS
[34]. Our microarray analysis did not find any discor-
dance related to the CNV between the twins.
The discordant phenotype could also be due to the
differences in the epigenome [7]. The epigenomic
changes (e.g., DNA methylation) are able to influence
the expression of the gene without affecting the DNA
sequence. The methylation of genomic DNA may affect
a variety of processes related to gene expression includ-
ing imprinting, chromosome inactivation and gene silen-
cing. Given the variety of developmental anomalies
associated with 22q11 deletions, it is logical to implicate
a methylation difference between the twins that would
alter the expression of some/most genes of this region.
We are unable to comment on this hypothesis at this
time due to various technical difficulties.
The discordant phenotype could also be due to the
early post zygotic second hit (mutation) in modifying
genetic factors (e.g., fgf8 at 10q24, fgf10 at 5p12-p13,
Gbx2 at 2q37, Pitx2 at 4q25, Vgef at 6p21.3, Tgfb at
1p34.1; Chordin at 3q27, Sonic hedgehog at 7q36, etc)
in one of the twins [9,35-40]. The second hit (mutation)
hypothesis may entail a variety of mutational mechan-
isms including replication errors, base changes and addi-
tional deletions involving LCR and Alu repeats of the
region. The second somatic hit hypothesis, however,
need not be restricted to the genetic changes at the
level of the DNA sequence but it may also involve the
epigenetic changes. Stalmans et al [36] provided evi-
d e n c et h a tv a r i a t i o ni nt h eg e n ee n c o d i n gv a s c u l a r
endothelial growth factor may modify the cardiovascular
phenotype with hemizygous for the 22q11.2 deletion.
Similarly, Driscoll et al [37] reported modifiers for pala-
tal phenotypes with this syndrome. It is known that the
genetic background influences the penetrance of cardio-
vascular, thymic, and parathyroid anomalies in the mice
[38,39]. Girirajan et al [41] proposed a ‘two-hit’ model,
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ment to result in a more severe clinical manifestation.
The second hit could potentially be another CNV, a dis-
ruptive single-base-pair mutation in a phenotypically
related gene or an environmental event that influences
the phenotype or altered deletion size as with our twins.
The two-hit model also helps to explain the underlying
phenotypic variability reported for several recurrent
microdeletions. The majority of second hits are probably
not detectable even by very high-resolution arrays.
Whole-genome re-sequencing may reveal a surprising
number of additional contributing loci.
Finally, the intrauterine environment or the twinning
process [11] itself, and non-genetic factors [42] may
influence phenotypic discordance. The twinning process
imposes a growth disadvantage that may be more severe
in one [8] thus may account for the discordance of mal-
formations in the twin pairs. Other influences of the
twinning process, which cause discordant cardiovascular
anomalies include the disturbance of laterality and the
placental vascular anastomoses.
We conclude that altered size of the deletion may
likely be the underlying etiology for the discordance in
the phenotype in our monozygotic twins. We think
early post zygotic mitotic non-allelic homologous
recombination could have been played a role in the
alteration of the size of 22q11.2 deletion and, thus the
phenotypic variability.
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